ZA200809857B - Terphenyl derivatives for treatment of alzheimer's disease - Google Patents

Terphenyl derivatives for treatment of alzheimer's disease

Info

Publication number
ZA200809857B
ZA200809857B ZA200809857A ZA200809857A ZA200809857B ZA 200809857 B ZA200809857 B ZA 200809857B ZA 200809857 A ZA200809857 A ZA 200809857A ZA 200809857 A ZA200809857 A ZA 200809857A ZA 200809857 B ZA200809857 B ZA 200809857B
Authority
ZA
South Africa
Prior art keywords
alzheimer
disease
treatment
terphenyl derivatives
terphenyl
Prior art date
Application number
ZA200809857A
Other languages
English (en)
Inventor
Wilson Francis
Reader Valerie
Harrison Richard John
Sunose Mihiro
Major Jeremy
Boussard Cyrille
Taylor Jess
Cansfield Andrew
Burckhardt Svenja
Jones Alison
Bell Kathryn
Morel Adeline
Hernadez-Perni Remedios
Ho Chih Yung
Original Assignee
Ortho Mcneil Janssen Pharmaceuticals Inc
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36293499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200809857(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Janssen Pharmaceuticals Inc, Cellzome Ltd filed Critical Ortho Mcneil Janssen Pharmaceuticals Inc
Publication of ZA200809857B publication Critical patent/ZA200809857B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200809857A 2006-04-21 2008-11-19 Terphenyl derivatives for treatment of alzheimer's disease ZA200809857B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112934A EP1847524B1 (en) 2006-04-21 2006-04-21 Terphenyl derivatives for treatment of Alzheimer's disease

Publications (1)

Publication Number Publication Date
ZA200809857B true ZA200809857B (en) 2009-08-26

Family

ID=36293499

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809857A ZA200809857B (en) 2006-04-21 2008-11-19 Terphenyl derivatives for treatment of alzheimer's disease

Country Status (35)

Country Link
US (1) US8106236B2 (xx)
EP (2) EP1847524B1 (xx)
JP (1) JP5422827B2 (xx)
KR (1) KR101494906B1 (xx)
CN (1) CN101484410B (xx)
AR (1) AR060621A1 (xx)
AT (1) ATE445586T1 (xx)
AU (1) AU2007240382B2 (xx)
BR (1) BRPI0710632A2 (xx)
CA (1) CA2649845C (xx)
CR (2) CR10376A (xx)
CY (1) CY1109729T1 (xx)
DE (1) DE602006009764D1 (xx)
DK (1) DK1847524T3 (xx)
EA (1) EA016908B1 (xx)
ES (2) ES2333539T3 (xx)
GE (1) GEP20115211B (xx)
HK (1) HK1134923A1 (xx)
IL (2) IL194853A0 (xx)
MA (1) MA30420B1 (xx)
MX (1) MX2008013447A (xx)
MY (1) MY148988A (xx)
NO (1) NO20084516L (xx)
NZ (1) NZ572999A (xx)
PE (1) PE20080267A1 (xx)
PL (1) PL1847524T3 (xx)
PT (1) PT1847524E (xx)
SI (1) SI1847524T1 (xx)
SM (1) SMP200800062B (xx)
TN (1) TNSN08414A1 (xx)
TW (1) TWI435720B (xx)
UA (1) UA95766C2 (xx)
UY (1) UY30300A1 (xx)
WO (1) WO2007124351A1 (xx)
ZA (1) ZA200809857B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1847524T3 (da) 2006-04-21 2010-01-11 Cellzome Ltd Terphenylderivater til behandling af Alzheimers sygdom
KR101618068B1 (ko) 2007-10-19 2016-05-04 얀센 파마슈티카 엔.브이. γ-세크레타아제의 탄소 결합된 조절제
US20090306392A1 (en) * 2007-10-19 2009-12-10 Chih Yung Ho Gsm intermediates
EP2212277B1 (en) 2007-10-19 2016-08-31 Janssen Pharmaceutica, N.V. Amine linked modulators of y-secretase
EP2212287B1 (en) 2007-10-19 2012-02-01 Janssen Pharmaceutica, N.V. PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
WO2009067493A2 (en) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
CN101896461A (zh) * 2007-12-13 2010-11-24 安姆根有限公司 γ分泌酶调节剂
CA2710477A1 (en) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
BRPI0908837A2 (pt) * 2008-03-11 2015-07-21 Neurosearch As Derivado de triarila, composição farmacêutica, uso de um derivado de triarila, e, método para tratar, prevenir ou para o alívio de uma doença, um distúrbio ou uma condição de um corpo de animal vivo
US7968725B2 (en) * 2008-07-22 2011-06-28 Janssen Pharmaceutica N.V. Pyridinyl modulators of γ-secretase
ES2583093T3 (es) * 2011-03-03 2016-09-19 Denovamed Inc. Compuestos antimicrobianos/adyuvantes
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
CN116528696A (zh) * 2020-11-27 2023-08-01 未来实验室生物科学有限公司 高纯度β烟酰胺单核苷酸（NMN）及其制造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08325182A (ja) * 1995-05-31 1996-12-10 Fuji Yakuhin Kogyo Kk 置換テルフェニル誘導体とそれらを含有する抗血栓剤
FR2767525B1 (fr) * 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
WO2000069823A1 (en) 1999-05-12 2000-11-23 Neurosearch A/S Ion channel modulating agents
EP1284729A4 (en) 2000-04-13 2007-12-19 Mayo Foundation REDUCTION AGENTS OF A (BETA) 42
JP2003531194A (ja) * 2000-04-24 2003-10-21 メルク フロスト カナダ アンド カンパニー プロスタグランジンｅ阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物
CA2438745C (en) * 2001-02-20 2010-11-30 Isis Innovation Limited Metal-containing dendrimers
FR2838439B1 (fr) * 2002-04-11 2005-05-20 Sanofi Synthelabo Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
EP1569954A1 (en) * 2002-12-05 2005-09-07 Axys Pharmaceuticals, Inc. Cyanomethyl derivatives as cysteine protease inhibitors
GB0305918D0 (en) 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
CN100441185C (zh) * 2003-04-30 2008-12-10 麦克弗罗斯特加拿大有限公司 8-(3-联芳基)苯基喹啉磷酸二酯酶-4抑制剂
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
EP1917262B1 (en) * 2005-08-15 2011-12-14 F. Hoffmann-La Roche AG Piperidine and piperazine derivatives as p2x3 antagonists
JP5155171B2 (ja) 2005-10-06 2013-02-27 アストラゼネカ・アクチエボラーグ 新規化合物
DK1847524T3 (da) 2006-04-21 2010-01-11 Cellzome Ltd Terphenylderivater til behandling af Alzheimers sygdom

Also Published As

Publication number Publication date
AR060621A1 (es) 2008-07-02
MA30420B1 (fr) 2009-05-04
TWI435720B (zh) 2014-05-01
UY30300A1 (es) 2007-08-31
EP2016039A1 (en) 2009-01-21
SMAP200800062A (it) 2008-11-19
IL194853A0 (en) 2009-08-03
CY1109729T1 (el) 2014-09-10
HK1134923A1 (en) 2010-05-20
MY148988A (en) 2013-06-28
SI1847524T1 (sl) 2010-01-29
JP5422827B2 (ja) 2014-02-19
WO2007124351A1 (en) 2007-11-01
ES2392352T3 (es) 2012-12-10
MX2008013447A (es) 2009-03-10
EA200802173A1 (ru) 2009-06-30
CR10376A (es) 2009-02-26
UA95766C2 (ru) 2011-08-25
TNSN08414A1 (en) 2010-04-14
PT1847524E (pt) 2009-12-18
BRPI0710632A2 (pt) 2011-08-23
EA016908B1 (ru) 2012-08-30
GEP20115211B (en) 2011-04-26
CN101484410A (zh) 2009-07-15
KR20090024678A (ko) 2009-03-09
AU2007240382A1 (en) 2007-11-01
DE602006009764D1 (de) 2009-11-26
ES2333539T3 (es) 2010-02-23
CR10452A (es) 2009-02-23
PE20080267A1 (es) 2008-05-16
PL1847524T3 (pl) 2010-03-31
CN101484410B (zh) 2013-08-21
NZ572999A (en) 2012-06-29
IL194789A0 (en) 2009-08-03
SMP200800062B (it) 2009-07-14
KR101494906B1 (ko) 2015-02-24
US20070254957A1 (en) 2007-11-01
EP1847524B1 (en) 2009-10-14
CA2649845C (en) 2014-09-16
CA2649845A1 (en) 2007-11-01
AU2007240382B2 (en) 2013-05-02
JP2009538275A (ja) 2009-11-05
US8106236B2 (en) 2012-01-31
EP1847524A1 (en) 2007-10-24
NO20084516L (no) 2009-01-13
EP2016039B1 (en) 2012-08-01
TW200810746A (en) 2008-03-01
DK1847524T3 (da) 2010-01-11
ATE445586T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
IL194789A0 (en) Terphenyl derivatives for treatment of alzheimer's disease
EP2151435A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ZA201006868B (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
EP2312945A4 (en) PURE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
EP2063889A4 (en) SPIROPIPERIDINE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
EP2382176A4 (en) USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL195571A0 (en) Compounds for the treatment of periodontal disease
EP2166854A4 (en) TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND ASSOCIATED STATES
EP2312946A4 (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200805839B (en) Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
EP2268647A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE IDENTIFICATION AND TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
ZA200909191B (en) Catecholamine derivatives useful for the treatment of parkinson's disease
EP2378879A4 (en) TRIAZONE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER
ZA200705018B (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease
EP1855679A4 (en) INHIBITORS OF AMINOMETHYL BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE
EP2379075A4 (en) TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
EP2349308A4 (en) COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2305629A4 (en) THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
IL208127A0 (en) Ptph1 inhibitors for the treatment of alzheimer's disease